Figures computed from official regulatory filings — .
Statistical track record
Free accountWin rates, median returns and the proven-insider analysis come with a free account.
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
PALVELLA THERAPEUTICS, INC.Listing unverified | Sell | $12.4M | Unusual size | SEC | |
PALVELLA THERAPEUTICS, INC.Listing unverified | Sell | $118.5K | SEC | ||
Loxo Oncology, Inc.Listing unverified | Sell | $3.2M | SEC | ||
Loxo Oncology, Inc.Listing unverified | Sell | $3.4M | SEC | ||
Loxo Oncology, Inc.Listing unverified | Sell | $7.5M | SEC | ||
Loxo Oncology, Inc.Listing unverified | Sell | $638.6K | SEC | ||
Loxo Oncology, Inc.Listing unverified | Sell | $5.4M | SEC | ||
RHYTHM PHARMACEUTICALS, INC.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
RHYTHM PHARMACEUTICALS, INC.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
RHYTHM PHARMACEUTICALS, INC.Listing on record | Buy | $6M | conv 45Cluster | SEC | |
Audentes Therapeutics, Inc.Listing unverified | Sell | $19M | SEC | ||
Sorrento Tech, Inc.Listing unverified | Sell | $727.2 | SEC | ||
Sorrento Tech, Inc.Listing unverified | Sell | $458.2 | SEC | ||
Sorrento Tech, Inc.Listing unverified | Sell | $48.1K | SEC | ||
Sorrento Tech, Inc.Listing unverified | Sell | $76.3K | SEC | ||
GLAUKOS CorpListing on record | Sell | $7.5M | SEC | ||
GLAUKOS CorpListing on record | Sell | $16K | SEC | ||
GLAUKOS CorpListing on record | Sell | $2.4M | SEC | ||
GLAUKOS CorpListing on record | Sell | $4.1M | SEC | ||
GLAUKOS CorpListing on record | Sell | $6.6M | SEC | ||
GLAUKOS CorpListing on record | Sell | $1.7M | SEC | ||
GLAUKOS CorpListing on record | Sell | $22.5K | SEC | ||
GLAUKOS CorpListing on record | Sell | $39.2K | SEC | ||
GLAUKOS CorpListing on record | Sell | $71.7K | SEC | ||
GLAUKOS CorpListing on record | Sell | $62.6K | SEC |